SCHEMBL22947703

SCHEMBL22947703

Clc1ccccc1-c1ccc2c(c1)S(c1ccccc1)(c1cccc3ccccc13)c1ccccc1-2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2A6 P11509 2/20 0.37
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36
BACE1 P56817 1/20 0.35
CYP1A1 P04798 2/20 0.34
CYP1B1 Q16678 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
ATM Q13315 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MCL1 Q07820 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947708 0.92 CYP1A2 (0.41) TRPA1CYP1A2CYP2A6JAK2JAK1
SCHEMBL22947475 0.87 CYP1A2 (0.37) CYP1A2CYP1A1CYP1B1KDM4EALDH1A1
SCHEMBL22947689 0.86 CYP2A6 (0.46) TRPA1CYP2A6JAK2JAK1TYK2
SCHEMBL22947595 0.82 MAPT (0.39) CYP1A2CYP1A1CYP1B1KDM4EALDH1A1
SCHEMBL22947722 0.81 MAPT (0.36) KDM4EALDH1A1RAB9AATMHSD17B10
SCHEMBL22947670 0.81 MAPT (0.38) KDM4EALDH1A1RAB9AATMHSD17B10
SCHEMBL22949099 0.81 MAPT (0.38) KDM4EALDH1A1RAB9AATMHSD17B10
SCHEMBL22949693 0.81 MAPT (0.38) KDM4EALDH1A1RAB9AATMHSD17B10
SCHEMBL22947666 0.81 MAPT (0.36) KDM4EALDH1A1RAB9AATMHSD17B10
SCHEMBL22947487 0.79 CYP1A2 (0.40) CYP1A2CYP2A6CYP1A1CYP1B1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 TRPA1 57/4885CYP1A2 281/4885CYP2A6 1117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.